Bracco introduces UPTUNITY aneurysm AI after FDA clearance
Bracco and Avicenna.AI introduce aneurysm detection and assessment software within a new clinical AI portfolio.

Bracco is building a clinical AI portfolio around radiology workflows.
What happened
Bracco and Avicenna.AI announced UPTUNITY | Aneurysm on 13 November. The software supports brain-aneurysm detection and assessment on CT angiography and introduces Bracco's UPTUNITY clinical-decision-support portfolio. The announcement follows an October FDA clearance decision for the underlying CINA-Aneurysm+ component.
Why it matters
The partnership connects a specialist imaging-AI developer with an established radiology supplier. That creates a route for decision-support software to reach the clinicians and institutions already using imaging products.
The bigger picture
Medical AI adoption involves distribution, integration and clinical reading processes. A portfolio approach gives a supplier a way to bring specialised tools into those existing relationships.
